RNAi is a Nobel Prize-winning technology that utilizes the power of nature's biological mechanisms to silence targeted genes.
As a platform company, Argo Biopharma has a rich product pipelines covering a wide range of indications: cardiovascular diseases, rare diseases, CNS diseases, viral hepatitis, metabolic diseases, etc.
